Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian M Slomovitz

Showing results (1-10 of 108) with videos related to

Pageof 11
Sort By:
Gynecologic Oncology|April 19, 2025
Rethinking metformin in advanced endometrial cancer: Scientific humility, translational challenges, and the urgency for equityVivek Podder, Brian M Slomovitz
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 15, 2025
Precision oncology in endometrial cancer: closing the gap between potential and practiceVivek Podder, Brian M Slomovitz
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 20, 2012
The PI3K/AKT/mTOR pathway as a therapeutic target in endometrial cancerBrian M Slomovitz, Robert L Coleman
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 24, 2026
Mirvetuximab soravtansine and low-grade serous ovarian cancer: innovation awaiting validationRobert L Coleman, Brian M Slomovitz
Current Oncology Reports|October 22, 2008
Uterine sarcoma 2008Jeff F Lin, Brian M Slomovitz
Gynecologic Oncology|January 31, 2004
Commenting on "HER2/neu overexpression: has the Achilles' heel of uterine serous papillary carcinoma been exposed? (88:263-5) by Santin AD"Brian M Slomovitz, Karen H Lu
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2015
Reply to G. Bogani et alBrian M Slomovitz, Robert L Coleman
Current Opinion in Obstetrics & Gynecology|December 30, 2021
Changing treatments paradigms and role of immunotherapy in recurrent endometrial cancerAnca Chelariu-Raicu, Haider Mahdi, Brian M Slomovitz
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 6, 2023
Immunotherapy in endometrial cancerHaider Mahdi, Anca Chelariu-Raicu, Brian M Slomovitz
Expert Review of Anticancer Therapy|April 30, 2026
An evaluation of avutometinib in combination with defactinib for <i>KRAS</i>-mutated recurrent low-grade serous ovarian cancerVivek Podder, Brian M Slomovitz, Robert L Coleman
Pageof 11

Showing results (1-10 of 108) with videos related to

Sort By:
Pageof 11
Gynecologic Oncology|April 19, 2025
Rethinking metformin in advanced endometrial cancer: Scientific humility, translational challenges, and the urgency for equityVivek Podder, Brian M Slomovitz
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 15, 2025
Precision oncology in endometrial cancer: closing the gap between potential and practiceVivek Podder, Brian M Slomovitz
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 20, 2012
The PI3K/AKT/mTOR pathway as a therapeutic target in endometrial cancerBrian M Slomovitz, Robert L Coleman
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 24, 2026
Mirvetuximab soravtansine and low-grade serous ovarian cancer: innovation awaiting validationRobert L Coleman, Brian M Slomovitz
Current Oncology Reports|October 22, 2008
Uterine sarcoma 2008Jeff F Lin, Brian M Slomovitz
Gynecologic Oncology|January 31, 2004
Commenting on "HER2/neu overexpression: has the Achilles' heel of uterine serous papillary carcinoma been exposed? (88:263-5) by Santin AD"Brian M Slomovitz, Karen H Lu
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2015
Reply to G. Bogani et alBrian M Slomovitz, Robert L Coleman
Current Opinion in Obstetrics & Gynecology|December 30, 2021
Changing treatments paradigms and role of immunotherapy in recurrent endometrial cancerAnca Chelariu-Raicu, Haider Mahdi, Brian M Slomovitz
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 6, 2023
Immunotherapy in endometrial cancerHaider Mahdi, Anca Chelariu-Raicu, Brian M Slomovitz
Expert Review of Anticancer Therapy|April 30, 2026
An evaluation of avutometinib in combination with defactinib for <i>KRAS</i>-mutated recurrent low-grade serous ovarian cancerVivek Podder, Brian M Slomovitz, Robert L Coleman
Pageof 11